The Nasty Shock When Cash Supplies Are Switched Off

A major pitfall of invoice financing techniques like supply-chain finance: Funding sources can be cut off just when they’re needed most.

When the global economy went into hibernation to try to halt the spread of Covid-19, companies everywhere scrambled to get their hands on cash. Banks, shareholders, and governments were all tapped for money, but self-help played a big part too. Businesses tried to clear their inventories, to get paid quickly for their products and services, and to pay their bills more slowly. A company that does all those things should have more funds in the bank to pay wages and other fixed costs—crucial if you want to survive an economic crisis of this scale.

As is so often the case, those creative types in the finance industry have come up with a smorgasbord of ways to help firms increase their cash holdings. The oldest and most common is called factoring. Essentially, if you’re a cash-strapped company whose customers are dragging their feet on paying their bills, no problem: A bank will give you an advance on those invoices, for a fee. Another increasingly fashionable technique is a more complicated service known as reverse factoring or supply-chain finance. This allows a company’s suppliers to quickly get paid what they’re owed. The company then refunds the finance provider at a later date.

Both of these techniques—known as “invoice financing”—generate chunky fees for banks and fintechs such as Greensill Capital, a reverse-factoring specialist backed by SoftBank’s Vision Fund. Viewed positively, these arrangements help keep the wheels of commerce oiled, especially at a time when supply chains face massive disruption—and uncertain payment schedules—because of the pandemic. In theory, they let everyone get their money reasonably quickly. However, this is really just another kind of short-term borrowing, and one that’s not well-understood by investors. It can lead to nasty surprises.

Most obviously, there’s the risk of fraud, where individuals raise financing against fake invoices. That may have contributed to the collapse of London-listed hospital operator NMC Health Plc, according to the Financial Times.

But the economic upheaval caused by the coronavirus has exposed other potential problems. If a company suddenly stops using invoice financing—either voluntarily or because its banks tighten credit terms—that can worsen its cash-flow difficulties at exactly the wrong moment. This happened when British contractor Carillion Plc collapsed two years ago. Furthermore, these arrangements aren’t always disclosed in a transparent way, making it difficult to get a full picture of a company’s accounts. Consider these four examples:

Taken together, these four cases show the pitfalls of this technique. If invoice financing can cease just when it is needed most, that’s all the more reason for investors to treat it as quasi-debt. And it’s imperative that disclosures, particularly around reverse factoring, be improved. Ultimately, investors need to understand exactly how a company is generating cash.

 

Copyright 2020 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.